Thymosin treatment of chronic hepatitis B combined matrine clinical observation

Objective:Of combined matrine treatment of chronic hepatitis B with thymosin clinical efficacy.Methods:128 cases of chronic hepatitis B were randomly divided into two groups and the control group,the observation group in the conventional application of thymosin Liver treatment combined matrine treatment while the control group were given thymosin,clinical symptoms were observed before and after treatment,liver function,HBV markers changes.Results:Clinical symptoms improved in the two groups is insignificant,improvement in liver function,HBeAg negative conversion rate,HBeAb seroconversion rate,HBVDNA conversion or down 10^3copies·ml^-1 above the rate,the observation group and comparisons,there are clear statistical significance (p0.05).Conclusion:Thymosin combined matrine is a good choice for chronic hepatitis B patients,in clinical trials to promote.